Breaking News

Mpox Vaccine Supply Outpaces Demand

January 19, 2023 • 5:09 pm CST
JYNNEOS Vaccine 1st and 2nd Doses
(Precision Vaccinations)

Since the Mpox outbreak began in May 2022, over 1.1 million doses of the Jynneos® vaccine have been administered in the United States (U.S.).

The city of Boston began offering Jynneos vaccinations to healthcare staff on May 24, 2022, followed by New York City (NYC). 

In September 2022, NYC Health began offering second doses of Jynneos to qualifying people.

As of January 17, 2023, 57 U.S. Jurisdictions have offered first and second doses to men and women at no charge.

From an effectiveness perspective, the U.S. Centers for Disease Control and Prevention (CDC) posted data on December 8, 2022, suggesting the effectiveness of a single dose of Jyennos was 87% protective.

Overall, the CDC has confirmed 30,026 Mpox cases and 23 related fatalities, a case-fatality rate of less than 1%.

Demetre Daskalakis, M.D., deputy coordinator of the CDC's pox response efforts in the U.S., recently posted on Twitter, 'Supply is there! We need to keep the drumbeat going for demand even as cases go down.'

'Getting vaccinated for #mpox now means protection in the future! Oh… that means two doses of the vaccine!

Find out where to obtain the Jynneos vaccine at http://mpoxvaxmap.org or your local/state health department.

Share